Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients (original) (raw)

Abstract

Purpose

To evaluate the hemostatic effects of transarterial infusion chemotherapy in addition to embolization (chemoembolization) for advanced primary lung cancer with tumor-related hemoptysis.

Materials and methods

Ten consecutive patients with stage IIIB/IV or recurrent primary lung cancer (squamous cell carcinoma in six, adenocarcinoma in four) who underwent chemoembolization for control of hemoptysis were enrolled. At enrollment, five patients were considered refractory and five had contraindications to standard therapies. The amount of hemoptysis was massive in two patients, moderate in seven, and slight in one. Transarterial infusion chemotherapy via feeding arteries using cisplatin (25 mg/m2) and 5-fluorouracil (300 mg/m2) was repeated every 3–4 weeks for three cycles. HepaSphere (100–150 µm) or gelatin sponge particles were selected as embolic materials depending on the presence of pulmonary shunts and were added for embolization just after drug infusion.

Results

Hemoptysis improved in all patients (resolution in nine, significant decrease in one). The median hemostasis time was 11.9 months (range 2.7–25.9 months). The target pulmonary lesions shrank in seven patients, and pulmonary atelectasis disappeared in three of five patients.

Conclusions

Chemoembolization may be a palliative option with favorable hemostasis time for advanced primary lung cancer with hemoptysis.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Masuda E, Sista AK, Pua BB, Madoff DC. Palliative procedures in lung cancer. Semin Interv Radiol. 2013;30:199–205.
    Article Google Scholar
  2. Kalva SP. Bronchial artery embolization. Tech Vasc Interv Radiol. 2009;12:130–8.
    Article PubMed Google Scholar
  3. Chun JY, Morgan R, Belli AM. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Interv Radiol. 2010;33:240–50.
    Article Google Scholar
  4. Hayakawa K, Tanaka F, Torizuka T, Mitsumori M, Okuno Y, Matsui A, et al. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Interv Radiol. 1992;15:154–8.
    Article CAS Google Scholar
  5. Park HS, Kim YI, Kim HY, Zo JI, Lee JH, Lee JS. Bronchial artery and systemic artery embolization in the management of primary lung cancer patients with hemoptysis. Cardiovasc Interv Radiol. 2007;30:638–43.
    Article Google Scholar
  6. Wang GR, Ensor JE, Gupta S, Hicks ME, Tam AL. Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 2009;20:722–9.
    Article PubMed Google Scholar
  7. Garcia-Olivé I, Sanz-Santos J, Centeno C, Andreo F, Munoz-Ferrer Serra P, et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J Vasc Interv Radiol. 2014;25:221–8.
    Article PubMed Google Scholar
  8. Fujita T, Tanabe M, Moritani K, Matsunaga N, Matsumoto T. Immediate and late outcomes of bronchial and systemic artery embolization for palliative treatment of patients with nonsmall-cell lung cancer having hemoptysis. Am J Hosp Palliat Care. 2014;31:602–7.
    Article PubMed Google Scholar
  9. Mehta AS, Ahmed O, Jilani D, Zangan S, Lorenz J, Funaki B, et al. Bronchial artery embolization for malignant hemoptysis: a single institutional experience. J Thorac Dis. 2015;7:1406–13.
    PubMed PubMed Central Google Scholar
  10. Nakanishi M, Yoshida Y, Natazuka T. Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy. Lung Cancer. 2012;77:353–8.
    Article PubMed Google Scholar
  11. Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Interv Radiol. 2013;36:1527–35.
    Article Google Scholar
  12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.
    Article CAS PubMed Google Scholar
  13. Vogl TJ, Lehnert T, Zangos S, Eichler K, Hammerstingl R, Korkusuz H, et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol. 2008;18:2449–55.
    Article PubMed Google Scholar
  14. Tanaka N, Yamakado K, Murashima S, Takeda K, Matsumura K, Nakagawa T, et al. Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system. J Vasc Interv Radiol. 1997;8:65–70.
    Article CAS PubMed Google Scholar
  15. White RI Jr. Bronchial artery embolotherapy for control of acute hemoptysis: analysis of outcome. Chest. 1999;115:912–5.
    Article PubMed Google Scholar
  16. Chang J, Zhou L, Wang S, Clifford Chao KS. Panoramic cone beam computed tomography. Med Phys. 2012;39:2930–46.
    Article PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka, 565-0814, Japan
    Akihiko Seki & Chigusa Shimono

Authors

  1. Akihiko Seki
    You can also search for this author inPubMed Google Scholar
  2. Chigusa Shimono
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toAkihiko Seki.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Cite this article

Seki, A., Shimono, C. Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients.Jpn J Radiol 35, 495–504 (2017). https://doi.org/10.1007/s11604-017-0659-2

Download citation

Keywords